(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

WUXIUP

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

WUXIUP

ST13

US500000079332544

Class

42

Filing

79332544

Registration

7057778

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

09/17/2023

Trademark type

Combined

Nice classes

42

Filing date

12/07/2021

Registration date

05/23/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/23/2023

Last transaction

05/23/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

IE

Examiner

LEE,YATSYE ISADORA

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "WUXIUP"; "WUX" is in black, "I" is in blue and "UP" is in yellow outlined by green. The line underneath the wording displays blue, green and yellow.

Holders and representatives

Holders

WUXI BIOLOGICS IRELAND LIMITED
WUXI BIOLOGICS CO., LTD.

Representatives

Michael T. Smith Birch Stewart Kolasch & Birch LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Development of products for others; pharmaceutical drug development; scientific research and development; pharmaceutical research; research and development of new products; consulting services in the field of pharmaceutical technology development; research and analysis of biochemistry; biomedical research; development of pharmaceutical preparations and medicines; research and development of antibodies

Publications

History of USPTO decisions and trademark events.

26 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

09/17/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/25/2023

FIMP

FINAL DISPOSITION PROCESSED

08/25/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/23/2023

CHLD

CHANGE OF OWNER RECEIVED FROM IB

08/18/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/23/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/23/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/07/2023

PUBO

PUBLISHED FOR OPPOSITION

03/07/2023

GPNX

NOTIFICATION PROCESSED BY IB

03/06/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/15/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/15/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/15/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/31/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/28/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/27/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/27/2022

RFNT

REFUSAL PROCESSED BY IB

12/21/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/29/2022

RFRR

REFUSAL PROCESSED BY MPU

11/29/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/21/2022

CNRT

NON-FINAL ACTION WRITTEN

09/20/2022

DOCK

ASSIGNED TO EXAMINER

09/15/2022

MAFR

APPLICATION FILING RECEIPT MAILED

02/08/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/04/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/03/2022

Continuous trademark protection

Get notified about every new filing that threatens WUXIUP or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.